Showing 1,701 - 1,720 results of 16,418 for search '"Therapy"', query time: 0.13s Refine Results
  1. 1701

    BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy by Vinay K. Pattalachinti, Emaan Haque, Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Michael Overman, Christine M. Parseghian, Van K. Morris, Bryan Kee, Ryan W. Huey, Kanwal Raghav, Colin M. Court, John Paul Shen

    Published 2025-02-01
    “…Abstract Appendiceal Adenocarcinoma (AA) is a rare gastrointestinal cancer with no FDA-approved targeted therapies. Here, we retrospectively compare BRAF-mutant AA and colorectal cancer (CRC). …”
    Get full text
    Article
  2. 1702
  3. 1703
  4. 1704

    Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

    Published 2024-08-01
    “…Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). This review addresses these conundrums in light of Pasteur’s principle that “the terrain is as important as the germ”. …”
    Get full text
    Article
  5. 1705
  6. 1706

    Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure of Helicobacter pylori Infection by Sander Veldhuyzen van Zanten, Snehal Desai, Linda Best, Geraldine Cooper-Lesins, Dickran Malatjalian, David Haldane, Kevork Peltekian

    Published 2010-01-01
    “…OBJECTIVE: To evaluate the efficacy of rescue therapy using rifabutin, amoxicillin and a proton pump inhibitor (PPI) in the eradication of Helicobacter pylori in patients who have failed at least one course of PPI-based triple therapy.…”
    Get full text
    Article
  7. 1707
  8. 1708

    Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy by Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, Nobuharu Tamaki, Kaoru Tsuchiya, Yutaka Yasui, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Takehiro Akahane, Eisuke Okamoto, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Namiki Izumi

    Published 2025-01-01
    “…Conclusions Severe proteinuria before lenvatinib as a second‐line therapy after atezolizumab‐bevacizumab treatment may affect the duration of lenvatinib administration and treatment efficacy.…”
    Get full text
    Article
  9. 1709

    Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes by Juan P. Cata, Claudius Conrad, Katy Rezvani

    Published 2015-01-01
    “…We believe that the use of NK cell transfer therapy in the context of postoperative minimal residual disease deserves significant investigation.…”
    Get full text
    Article
  10. 1710
  11. 1711

    The transformation of the image of God during the development of eating disorders and eventual therapy: a sociological study by Dariusz Tułowiecki

    Published 2022-12-01
    “… The text aims to present the image of God – a Higher Power being discovered as part of eating disorder therapy and the changes in the informant within her life. …”
    Get full text
    Article
  12. 1712

    The role of HSPA14 in breast cancer: implications for tumorigenesis, immune response modulation, and personalized therapies by Ruipeng Zhao, Xiaocun Zhu, Wan Wei, Linlin Zhen

    Published 2025-12-01
    “…The expression of HSPA14 may also indicate drug sensitivity.Conclusion Our study elucidates the involvement of HSPA14 in tumorigenesis, particularly in modulating the immune response, shaping the immune microenvironment, and contributing to drug resistance, which are pivotal for the development of personalized breast cancer therapies.…”
    Get full text
    Article
  13. 1713

    Directing Therapy in Pulmonary Arterial Hypertension Using a Target 6 Min Walk Distance by Nancy Rose Porhownik, Renelle Myers, Zoheir Bshouty

    Published 2013-01-01
    “…BACKGROUND: The most effective approaches to escalating advanced therapies in pulmonary arterial hypertension (PAH) are controversial.…”
    Get full text
    Article
  14. 1714

    Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients by Long-Shan Ji, Qiu-Tian Gao, Ruo-Wen Guo, Xin Zhang, Zhen-Hua Zhou, Zhuo Yu, Xiao-Jun Zhu, Ya-Ting Gao, Xue-Hua Sun, Yue-Qiu Gao, Man Li

    Published 2019-01-01
    “…Patients were categorized into a treatment group (T-Group: combination therapy with BSF plus ETV) and a control group (C-Group: ETV). …”
    Get full text
    Article
  15. 1715
  16. 1716

    Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma. by Lei Yang, Kien Pham, Yibo Xi, Qunfeng Wu, Dongfang Liu, Keith D Robertson, Chen Liu

    Published 2025-01-01
    “…These findings highlight the effective anti-HCC effects of NK92MI/HN3 cells and reveal the role of GPC3 isoforms in influencing therapy outcomes, suggesting that isoform analysis should be considered to optimize CAR-NK therapies to improve patient outcomes.…”
    Get full text
    Article
  17. 1717
  18. 1718

    Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning by Ying Zhang, Fabao Xu, Zhenzhe Lin, Jiawei Wang, Chao Huang, Min Wei, Weibin Zhai, Jianqiao Li

    Published 2022-01-01
    “…To predict visual acuity (VA) 1 month after anti-vascular endothelial growth factor (VEGF) therapy in patients with diabetic macular edema (DME) by using machine learning. …”
    Get full text
    Article
  19. 1719

    Effect Of Exercise Therapy on Lipid Profile and Oxidative Stress Indicators in Patients with Type 2 Diabetes by Madeeha Jadoon, Shazia Zeb, Sajid Razaq, Munazza Khan, Muhammad Shoaib, Sara Mariyum

    Published 2024-09-01
    Subjects: “…Keywords: Exercise Therapy, Type 2 Diabetes Mellitus, Lipid Profile, Oxidative Stress…”
    Get full text
    Article
  20. 1720

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
    Get full text
    Article